← Open Payments lookup

AMANDA BERGER: Open Payments

NPI 1578335709 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,543 in 72 payments from 15 companies in 2025. Trend: 2023 $44 · 2024 $1,910 · 2025 $1,543

Food & beverage: $1,543
CompanyPaymentsAmount
ABBVIE INC.16$270
Alkermes, Inc.10$250
Neurocrine BioSciences, Inc.7$181
Teva Pharmaceuticals USA, Inc.7$143
Almatica Pharma LLC5$133
Lundbeck LLC5$104
E.R. Squibb & Sons, L.L.C.5$102
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$70
Collegium Pharmaceutical, Inc.3$62
Indivior Inc.2$61

Products named: VRAYLAR, ARISTADA, INGREZZA, UZEDY, LOREEV XR, REXULTI, COBENFY, CAPLYTA.

Industry payments across MD — which companies pay providers there.